Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib.
Broxterman, Henk J
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. [electronic resource] - Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy - 114-26 p. digital
Publication Type: Comparative Study; Journal Article; Review
1532-2084
10.1016/j.drup.2009.07.001 doi
Antineoplastic Agents--pharmacokinetics
Doxorubicin--pharmacokinetics
Drug Resistance, Multiple--genetics
Drug Resistance, Neoplasm--genetics
Humans
Indoles--pharmacology
Neoplasms--drug therapy
Pyrroles--pharmacology
Sunitinib
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. [electronic resource] - Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy - 114-26 p. digital
Publication Type: Comparative Study; Journal Article; Review
1532-2084
10.1016/j.drup.2009.07.001 doi
Antineoplastic Agents--pharmacokinetics
Doxorubicin--pharmacokinetics
Drug Resistance, Multiple--genetics
Drug Resistance, Neoplasm--genetics
Humans
Indoles--pharmacology
Neoplasms--drug therapy
Pyrroles--pharmacology
Sunitinib